Critical Therapeutics' Zyflo shows positive results

JenniferInez Ward

SAN FRANCISCO (MarketWatch) -- Critical Therapeutics Inc.
crtx
said after Monday's closing bell that two studies show its treatment Zyflo Filmtab was effective in patients with moderate to severe asthma. The data is from post-hoc analyses of pivotal trials for the treatment. Zyflo was approved in 1996 by the Food and Drug Administration for the prevention and treatment of asthma in adults and children 12 years of age and older. Results from the studies were presented at the American Thoracic Society 2005 International Conference, the company said.

Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.